Benzinga's Top Upgrades, Downgrades For October 22, 2018

Raymond James upgraded Occidental Petroleum Corporation OXY from Outperform to Strong Buy. Occidental Petroleum shares rose 1.5 percent to $73.25 in pre-market trading.
Analysts at Nomura upgraded Intel Corporation INTC from Neutral to Buy. Intel shares rose 1.7 percent to $44.74 in pre-market trading.
Deutsche Bank upgraded Lennar Corporation LEN from Hold to Buy. Lennar shares rose 1.2 percent to $41.31 in pre-market trading.
BMO Capital upgraded Louisiana-Pacific Corporation LPX from Underperform to Market Perform. Louisiana-Pacific shares fell 0.09 percent to close at $21.80 on Friday.
Tigress Financial upgraded AT&T Inc. T from Neutral to Buy. AT&T shares rose 0.4 percent to $33.00 in pre-market trading.
RBC Capital upgraded Chipotle Mexican Grill, Inc. CMG from Sector Perform to Outperform. Chipotle shares rose 1.7 percent to $436.00 in pre-market trading.
Piper Jaffray upgraded M&T Bank Corporation MTB from Neutral to Overweight. M&T Bank shares closed at $162.63 on Friday.
Argus upgraded United Rentals, Inc. URI from Hold to Buy. United Rentals shares rose 1 percent to $118.25 in pre-market trading.
Deutsche Bank upgraded Lennar Corporation LEN from Hold to Buy. Lennar shares rose 1.2 percent to $41.31 in pre-market trading.
Bank of America upgraded Financial Group Inc CFG from Underperform to Buy. Citizens Financial shares rose 5.9 percent to $38.50 in pre-market trading.

Morgan Stanley downgraded Union Pacific Corporation UNP from Equal-Weight to Underweight. Union Pacific shares rose 0.12 percent to close at $148.70 on Friday.
Citigroup downgraded Bristol-Myers Squibb Co BMY from Buy to Neutral. Bristol-Myers Squibb shares dropped 2.9 percent to $52.75 in pre-market trading.
Raymond James downgraded Copa Holdings, S.A. CPA from Strong Buy to Market Perform. Copa shares fell 1.76 percent to close at $75.57 on Friday.
Morgan Stanley downgraded Genesee & Wyoming Inc GWR from Equal-Weight to Underweight. Genesee & Wyoming shares fell 0.29 percent to close at $81.14 on Friday.
Evercore ISI Group downgraded UDR, Inc. UDR from In-Line to Underperform. UDR shares rose 0.82 percent to close at $39.39 on Friday.
Keefe Bruyette & Woods downgraded Horizon Technology Finance Corp HRZN from Market Perform to Underperform. Horizon Tech Finance shares fell 1.4 percent to $11.30 in pre-market trading.
Wedbush downgraded Wingstop Inc WING from Outperform to Neutral. Wingstop shares fell 1.3 percent to $69.89 in pre-market trading.
Deutsche Bank downgraded Toll Brothers Inc TOL from Buy to Hold. Toll Brothers shares closed at $30.02 on Thursday.
Bank of America downgraded eBay Inc EBAY from Buy to Neutral. eBay shares fell 1.9 percent to $28.21 in pre-market trading.
Longbow Research downgraded Reliance Steel & Aluminum Co RS from Buy to Neutral. Reliance Steel shares closed at $81.07 on Friday.

Goldman Sachs initiated coverage on Arco Platform Ltd ARCE with a Buy rating. The price target for Arco Platform is set to $26. Arco Platform shares closed at $22.75 on Friday.
Buckingham initiated coverage on Fastenal Company FAST with a Neutral rating. The price target for Fastenal is set to $50. Fastenal shares closed at $52.00 on Friday.
Analysts at Jefferies initiated coverage on Urovant Sciences Ltd UROV with a Buy rating. The price target for Urovant Sciences is set to $19. V shares closed at $12.68 on Friday.
Analysts at Chardan Capital initiated coverage on Seres Therapeutics Inc MCRB with a Buy rating. The price target for Seres Therapeutics is set to $15. Seres Therapeutics closed at $6.53 on Friday.
Morgan Stanley initiated coverage on Exela Technologies Inc XELA with an Overweight rating. The price target for Exela Technologies is set to $9. Exela Technologies shares closed at $6.34 on Friday.
Analysts at Cowen & Co. initiated coverage on Sutro Biopharma Inc STRO with an Outperform rating. Sutro Biopharma shares closed at $14.53 on Friday.
Wedbush initiated coverage on Entasis Therapeutics Holdings Inc ETTX with an Outperform rating. The price target for Entasis Therapeutics is set to $19. Entasis Therapeutics shares closed at $7.44 on Friday.

Analyst Calendar